VA
AMGN icon

Vident Advisory’s Amgen AMGN Stock Holding History

Vident Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.71M Buy
27,604
+9,252
+50% +$3.3M 0.08% 209
2025
Q4 		$6.01M Sell
18,352
-1,382
-7% -$438K 0.05% 284
2025
Q3 		$5.57M Buy
19,734
+1,468
+8% +$426K 0.05% 277
2025
Q2 		$5.1M Buy
18,266
+417
+2% +$118K 0.06% 272
2025
Q1 		$5.56M Sell
17,849
-1,482
-8% -$438K 0.08% 215
2024
Q4 		$5.04M Buy
19,331
+12,250
+173% +$3.63M 0.09% 209
2024
Q3 		$2.28M Buy
7,081
+1,757
+33% +$575K 0.06% 352
2024
Q2 		$1.66M Sell
5,324
-110,182
-95% -$32.4M 0.05% 431
2024
Q1 		$32.8M Buy
115,506
+47,918
+71% +$14M 0.68% 20
2023
Q4 		$19.5M Sell
67,588
-12,605
-16% -$3.43M 0.49% 36
2023
Q3 		$21.6M Buy
+80,193
New +$20M 0.67% 20

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vident Advisory's AMGN Position: Q1 2026 in Review

Vident Advisory increased its Amgen (AMGN) stake by 50% in Q1 2026, buying an estimated $3.3M and bringing the position to 27,604 shares worth $9.71M. The position accounts for 0.08% of the portfolio, ranked #209.

Vident Advisory first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $32.8M in Q1 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Vident Advisory held 27,604 shares of Amgen worth $9.71M as of Q1 2026.
  • Vident Advisory bought 9,252 Amgen shares in Q1 2026, an estimated $3.3M.
  • Amgen made up 0.08% of Vident Advisory's portfolio in Q1 2026, its #209 holding.
  • Vident Advisory first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Amgen position peaked at $32.8M in Q1 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.